ACQUATI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 7.159
EU - Europa 6.286
AS - Asia 1.415
SA - Sud America 198
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 15
OC - Oceania 15
Totale 15.108
Nazione #
US - Stati Uniti d'America 7.133
IT - Italia 3.077
DE - Germania 827
UA - Ucraina 774
SE - Svezia 513
SG - Singapore 375
CN - Cina 358
TR - Turchia 343
IE - Irlanda 276
VN - Vietnam 251
FI - Finlandia 232
RU - Federazione Russa 225
BR - Brasile 178
GB - Regno Unito 139
FR - Francia 66
NL - Olanda 41
BE - Belgio 33
JP - Giappone 23
EU - Europa 20
CZ - Repubblica Ceca 19
CA - Canada 18
AT - Austria 17
IN - India 15
AU - Australia 14
BG - Bulgaria 9
AR - Argentina 7
HK - Hong Kong 7
ZA - Sudafrica 6
DK - Danimarca 5
IQ - Iraq 5
TN - Tunisia 5
UZ - Uzbekistan 5
VE - Venezuela 5
ES - Italia 4
LT - Lituania 4
MY - Malesia 4
PK - Pakistan 4
PT - Portogallo 4
AZ - Azerbaigian 3
BD - Bangladesh 3
EC - Ecuador 3
LU - Lussemburgo 3
PL - Polonia 3
RO - Romania 3
TW - Taiwan 3
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
RS - Serbia 2
SA - Arabia Saudita 2
AL - Albania 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
UG - Uganda 1
UY - Uruguay 1
Totale 15.108
Città #
Milan 1.844
Chandler 822
Fairfield 809
Jacksonville 591
Ashburn 500
Woodbridge 480
Houston 448
Wilmington 340
Seattle 333
Ann Arbor 327
Como 295
Dublin 276
Cambridge 268
Nyköping 256
Princeton 245
Dearborn 210
Boardman 199
Izmir 169
Singapore 166
Rome 144
New York 128
Beijing 125
Dong Ket 108
San Mateo 75
San Diego 63
Chicago 61
Ogden 57
Helsinki 51
Los Angeles 48
Frankfurt am Main 34
Munich 34
Casorezzo 33
Washington 32
Brussels 30
Dallas 30
The Dalles 30
Kocaeli 29
Redmond 28
Santa Clara 26
Des Moines 23
Gallarate 22
Hefei 22
Varese 22
Nanjing 21
Ponte Lambro 21
London 20
Düsseldorf 19
São Paulo 18
Guangzhou 17
Magnago 17
Berlin 16
Kunming 16
Verona 16
Nuremberg 15
Tokyo 14
Toronto 14
Amsterdam 12
Falkenstein 12
Norwalk 12
Brno 11
Edinburgh 10
San Genesio Ed Uniti 10
Vienna 10
Lappeenranta 9
Nanchang 9
Pune 9
Shenyang 9
Bulgorello 8
Espoo 8
Shanghai 8
West Jordan 8
Zhengzhou 8
Jinan 7
Olomouc 7
Rozzano 7
Auburn Hills 6
Brasília 6
Hebei 6
Sofia 6
Torino 6
Vigevano 6
Assago 5
Changsha 5
Chengdu 5
Chiswick 5
Council Bluffs 5
Curitiba 5
Falls Church 5
Fuzhou 5
Hangzhou 5
Hong Kong 5
Hounslow 5
Islington 5
Meda 5
Monza 5
Redwood City 5
Southwark 5
Sydney 5
Baghdad 4
Belo Horizonte 4
Totale 10.360
Nome #
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis 233
Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins 204
Human recombinant RNASET2-induced inflammatory response and connective tissue remodeling in the medicinal leech. 202
AIF-1 and RNASET2 Play Complementary Roles in the Innate Immune Response of Medicinal Leech 202
Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase 201
Characterization by yeast artificial chromosome cloning of the linked apolipoprotein(a) and plasminogen genes and identification of the apolipoprotein(a) 5' flanking region 186
Ten allelic apolipoprotein[a] 5' flanking fragments exhibit comparable promoter activities in HepG2 cells 184
In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6. 183
New strategies for expression and purification of recombinant human RNASET2 protein in Pichia pastoris 181
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 175
The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the Down critical region 172
A 2-Mb YAC contig linking the plasminogen-apoprotein(a) gene family to the insulin-like growth factor 2 receptor (IGF2R) gene on the telomeric region of chromosome 6 (6q26-q27). 169
Characterization of multiple enhancer regions upstream of the apolipoprotein(a) gene. 168
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells 167
RNASET2 silencing affects miRNAs and target gene expression pattern in a human ovarian cancer cell model 167
Topological Properties of Co-Occurrence Networks in Published Gene Expression Signatures. 163
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 163
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro 163
A cell-autonomous oncosuppressive role of human RNASET2 affecting ECM-mediated oncogenic signaling 163
Nonsyndromic total anomalous venous return associated with a de novo translocation inolving chromosomes 10 and 21 t(10;21)(q23.1;q11.2) 162
Influence of metal ions on gene expression of BALB 3T3 fibroblasts 160
The human genome project and the discovery of genetic determinants of cancer susceptibility 159
Biochemical and immunohistochemical characterization of human RNASET2 expression 158
Cloning and transposon vectors derived from satellite bacteriophage P4 for genetic manipulation of Pseudomonas and other gram-negative bacteria. 157
Comparison of the baculovirus-insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2 156
Response of human cord blood cells to styrene exposure: evaluation of its effects on apoptosis and gene expression by genomic technology 155
Human growth hormone increases apo(a) expression in transgenic mice 153
Molecular characterisation of the human apo(a)-plasminogen gene family clustered on the telomeric region of chromosome 6 (6q26-27). 149
Intracellular trafficking of RNASET2, a novel component of P-bodies 149
Molecular cloning, tissue distribution, and chromosomal localization of the human homolog of the R2/Th/Stylar ribonuclease gene family 146
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis 146
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas 146
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 146
Demonstration of physical linkage between the promoter region and the polymorphic kringle IV domain in the Apo(a) gene by pulsed-field gel electrophoresis. 145
Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation. 145
DYSREGULATED EXPRESSION OF ANKYRIN REPEAT DOMAIN 1 IN THE DEVELOPING MYOCARDIUM CAUSES ANOMALOUS VENOUS RETURN AND MORPHOGENETIC DEFECTS BY IMPAIRING CARDIAC REMODELLING 145
Naphthalene exposure: Effects on gene expression and proliferation in human cord blood cells 144
New insights into hypoxia-related mechanisms involved in different microvascular patterns of bronchopulmonary carcinoids and poorly differentiated neuroendocrine carcinomas. Role of ribonuclease T2 (RNASET2) and HIF-1 α 140
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene 139
Human allantoicase gene: cDNA cloning, genomic organization and chromosome localization 138
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return 137
RNASET2 - An autoantigen in anaplastic large cell lymphoma identified by protein array analysis. 137
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene 132
Transgenic mice expressing a human apolipoprotein[a] allele 131
RNASET2 as a tumor antagonizing gene in a melanoma cancer model 130
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system 130
Muscle development and differentiation in the urodele Ambystoma mexicanum. 129
Molecular characterization of RNASE6PL, a putative human tumor suppressor gene on chromosome 6q27. 127
The antibacterial role of Hirudo verbana RNASET2: evaluation in vivo and in vitro 127
3D reconstruction of HvRNASET2 molecule to understand its antibacterial role 127
A hedgehog homolog is involved in muscle formation and organization of Sepia officinalis (mollusca) mantle. 126
TLR2 expression in medicinal leech 125
Caratterizzazione Molecolare della traslocazione t(10;21) in un paziente affetto da Ritorno Venoso Polmonare Anomalo Totale (TAPVR) 124
Prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6 121
A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast 121
Ribonuclease T2 (RNASET2) expression in the spectrum of neuroendocrine neoplasms of the lung. Relationships with hypoxia-related mechanisms and microvascular patterns 121
The human RNASET2 tumor antagonizing gene as a novel stress-response gene potentially involved in microenvironment-mediated tumor suppression 120
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene 120
RNASET2 (ribonucleaseT2) 118
Caratterizzazione strutturale e funzionale di rnase6pl, un putativo gene oncosoppressore localizzato sul cromosoma 6 umano 115
Antimicrobial role of RNASET2 protein during innate immune response in the medicinal leech Hirudo verbana 114
Regulation of macrophage differentiation and polarization pattern by human RNASET2 protein 113
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours 112
Cellular and biochemical characterization of the human member of Rh/T2/S ribonucleases 112
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations. 110
Tumor and metastasis suppression by the human RNASET2 gene. 109
Human RNASET2 as a candidate stress-response gene involved in non-cell autonomous tumor suppression. 109
STUDIO FUNZIONALE DI RNASE6PL, PUTATIVO GENE ONCOSOPRESSORE LOCALIZZATO IN 6Q27 108
Chromosome 6 abnormalities in borderline ovarian tumours suggest a genetic continuum in the progression model of ovarian neoplasms. 108
Common fragile site FRA6E spans at least 7,5 Mb 107
AIF-1 and RNASET2 play different roles in the modulation of leech innate immune response 107
Microarray expression studies on bone marrow of patients with Shwachman-Diamond syndrome in relation to deletion of the long arm of chromosome 20, other chromosome anomalies or normal karyotype 107
The rnaset2 oncosuppressor protein regulates both differentiation and polarization in human macrophages 107
Intracellular levels of the ANKRD1/CARP cardiac transcription repressor are regulated by the 26S proteasome 104
DIFFERENT BUT COMPLEMENTARY ROLES OF RNASET2 AND AIF-1 IN THE MODULATION OF MEDICINAL LEECHES INNATE IMMUNE RESPONSE 104
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 103
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells 103
Sviluppo e differenziamento muscolare nell'urodelo Ambystoma Mexicanum 103
Regionalized expression of Ankirin Repeat Domain 1 gene is essential to regulate multiple aspects of sinoatrial development and ventricular trabeculation 103
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene. 101
The pleiotropic roles of the human RNASET2 tumor suppressor gene 101
Genomic structure and organization of kringles type 3 to 10 of the apolipoprotein(a) gene in 6q26-27. 100
Cloning and characterization of human and Xenopus allantoicase 99
Molecular characterisation of human common fragile site FRA6E, a large genomic region spanning 9 Mb 99
Molecular characterization of the t(10;21) translocation breakpoint ina total anomalous pulmonary venous return patient 97
The Human RNASET2 gene as a key component in the microenvironmental control of cancer growth 97
The oncosuppressive role of RNASET2 gene in a mouse tumor syngeneic model 96
Ritorno Venoso polmonare Anomalo Totale: CARP, un possibile gene candidato 94
Expression studies in patients with Shwachman Diamond syndrome in relation to clonal chromosome anomalies in bone marrow 94
BACE2 is stored in secretory granules of mouse and rat pancreatic beta cells 94
Are Tumor Suppressor Genes Playing a Role in the Deregulation of Tissue Organization in Cancer? 93
Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection 92
Reporter gene analysis of four DNaseI hypersensitive sites in the plasminogen/apolipoprotein(a) intergenic region. 91
Identification of putative cancer-related antisense transcripts in 6q21 and 6q27 91
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression 90
Molecular and functional characterization of a candidate gene for total anomalous pulmonary venous return 89
The human recombinant RNASET2 activates the initial phase of the inflammatory response in the medicinal leech 89
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 86
RNASET2 is a non-cell autonomous human tumor suppressor 86
Chromosome instability suggests progression model in ovarian carcinogenesis 85
Totale 13.109
Categoria #
all - tutte 63.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020609 0 0 0 0 0 0 0 0 156 192 121 140
2020/20212.082 44 246 100 173 101 193 180 194 280 143 183 245
2021/20221.484 160 170 106 91 85 70 114 104 81 186 128 189
2022/20232.133 200 166 171 227 142 419 14 336 239 67 89 63
2023/20243.271 467 472 461 573 647 280 38 63 93 40 43 94
2024/20251.633 46 35 403 181 130 160 148 230 300 0 0 0
Totale 15.315